Pharmaceutical and biological leading stocks are:Hengrui Medicine(600276), Fosun Pharmaceutical(600196), Yunnan Baiyao(000538), Xinlite(002294), Kelaiying(002821), Aier Ophthalmology(300015), Pientzehuang(600436). Below is a detailed description of these stocks, interested investors can continue reading.
What are the leading pharmaceutical and biological stocks?
Stock Name
Stock Code
Sector
Industry Class
Reason for Affiliation
Hengrui Medicine
600276
Shanghai
Chemistry Pharmaceuticals
It is the first and the leader in China's innovative drug development. It is a leading company in China's innovative drug field with a complete product mix and R&D channels. It is a leader in innovative drug development. Piratinib is independently developed by the company 1. An innovative drug is the company's heavy bomb product. Piratinib has a $1.4 billion market for breast cancer indications, and future indications will be expanded to include lung and stomach cancer.
Fosun Pharma
600196
Shanghai
Biopharmaceuticals II
Fuhong Hanklin is a platform for the research and development and production of biopharmaceuticals, and owns 61.093 shares of the company, with biosimilars leading the way in China in terms of research and development strength and progress. It is expected that biosimilars such as rilituximab, trastuzumab and adalimumab will be approved in the next three years. The biosimilars market is large, with many heavyweight products, high barriers to entry and low Medicare support. In the long run, they are optimistic about the oligopoly competition model.
Yunnan Baiyao
000538
Shenzhen
Chinese Medicine II
The company is one of China's leading manufacturers of proprietary Chinese medicines. It is one of the top 50 proprietary Chinese medicine companies. The company's main products include Yunnan Baiyao and natural botanicals, with 19 dosage forms and more than 300 varieties, and its sales volume ranks first in Yunnan Province. At present, the company also owns Yunnan Baiyao Bulk and Yunnan Baiyao Capsules, which are national-level protected proprietary Chinese medicines. On August 18, 2017, Yunnan Baiyao was selected for the 2017 China Health Brand List and Brand Value List.
Xinlitai
002294
Small and medium-sized board
Chemical Pharmaceuticals
Shenzhen Litai Pharmaceuticals Ltd. inside and outside the expansion of the medical equipment ladder, is a double force. The company focuses on the development of cardiovascular specialty drugs, innovative drugs and unique products. Existing patented drugs have unique advantages, forming a pyramid product structure radiating from high-end to downward. Innovative drugs are progressing well and clinical use of flucytosine is underway. The novel anti-heart failure drug S glucagon-like peptide-1-Fc injectable fusion protein has been accepted.
Kellettin
600166
Shanghai
Chemical Pharmaceuticals
Kellettin Pharmaceuticals Group (Tianjin) Co., Ltd. is dedicated to the technological innovation and commercial use of global pharmaceutical technologies, and provides comprehensive pharmaceutical outsourcing services to mainstream international pharmaceutical companies. Its scope mainly includes the development of new drugs in the clinical stage, preparation and marketing of pharmaceuticals. Process optimization and large-scale production take place at the commercialization stage. Domestic CMOs engage in custom R&D and custom life one-stop services through CDMOs, providing many domestic pharmaceutical companies with Class 1.1 new drug R&D services; representative new drugs: treatment of hepatitis C, cardiovascular diseases, gallbladder fibers and so on.
Aier Ophthalmology
600418
Shanghai
Medical Services
The company is one of the largest ophthalmology healthcare organizations in China. Aier Eye Hospital Group Ltd. is an eye care provider. The company mainly provides patients with ophthalmic medical services, such as diagnosis, treatment of various eye diseases, optometry and dispensing glasses.In 2008 and 2009, the company stood out among China's Most Valuable Companies in 2008 and 2009, and was selected as one of the Top 50 Most Valuable Companies in China for Zero Technology for two consecutive years.
Pientzehuang
600436
Shanghai
Chinese Medicine II
Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. is a company which mainly produces and sells medical products such as ingots, tablets, granules and other medical products as well as tourism products. At present the main business at present is the production and sale of traditional Chinese medicine. In recent years, daily necessities and cosmetics are growing rapidly. The Company's new strategy of one core and two wings is based on the production of traditional Chinese medicine, with healthcare medicines, health food, functional beverages, specialty cosmetics, and daily chemical products as the two wings, supplemented by the distribution of pharmaceutical products. The company will take Pientzehuang, a strong brand with a hundred-year history, as the foundation to open the way for the future growth of branded Chinese medicine consumer products.